ArticleArchives of Iranian medicine2026
Mortality Trend of Cerebrovascular Disorders: A Cross-sectional Study in Northern Iran (2016-2023).
Article in Archives of Iranian medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCerebrovascular disorders (CeVDs) are among the leading causes of death worldwide. This study aims to analyze the trends in mortality due to CeVDs in northern Iran between 2016 and 2023.
methodsIn this cross-sectional study, we included all documented Deaths due to CeVDs in Babol County, north of Iran, from 2016 to 2023. The crude mortality rate (CMR) and age-standardized mortality rate (ASMR) were used to assess the trends in CeVDs mortality. The Cochran-Armitage trend test and Joinpoint regression were employed to analyze the changes in disease trends.
resultsDuring the study period, a total of 1,798 deaths from CeVDs were reported, with a mean age of 76.8±13.2 years. The CMR and ASMR for CeVDs decreased from 38.4 and 28.3 per 100,000 population in 2016 to 30.9 and 23.3 per 100,000 in 2023 (
conclusionThis study reveals a significant decrease in CeVDs mortality in the region, indicating progress in therapeutic interventions. However, death rates in rural areas remain high. Addressing this condition requires targeted approaches and increased resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.